123-I-MIP-1095
Term · Oncology and biomedicine · MLC-T-ONC-009512
An iodine 123-radiolabled small molecule that exhibits high affinity for prostate-specific membrane antigen (PSMA) with potential use in molecular imaging. 123-I-MIP-1095, a radiolabeled glutamate-urea-lysine analogue, selectively binds PSMA, which allows imaging of PSMA-expressing prostate cancer cells with gamma scintigraph. PSMA is a transmembrane glycoprotein highly expressed by malignant prostate epithelial cells and vascular endothelial cells of various solid tumors.
| Identifier | MLC-T-ONC-009512 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | iodine I 123 IMP-1095 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-009512",
"term": "123-I-MIP-1095",
"field": "Oncology and biomedicine",
"definition": "An iodine 123-radiolabled small molecule that exhibits high affinity for prostate-specific membrane antigen (PSMA) with potential use in molecular imaging. 123-I-MIP-1095, a radiolabeled glutamate-urea-lysine analogue, selectively binds PSMA, which allows imaging of PSMA-expressing prostate cancer cells with gamma scintigraph. PSMA is a transmembrane glycoprotein highly expressed by malignant prostate epithelial cells and vascular endothelial cells of various solid tumors.",
"expansions": [
"iodine I 123 IMP-1095"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/123-i-mip-1095/"
}
Record 10 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.